CVS Group plc
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
Block Listing Application
CVS, one of the UK's leading providers of integrated veterinary services, announces that an application has been made to the London Stock Exchange for a block listing of 114,302 new ordinary shares of 0.2p each in the Company ("Ordinary Shares") to be admitted to trading on AIM.
The Ordinary Shares will be issued from time to time pursuant to the exercise of share options under the Company's 2017-2020 SAYE sharesave scheme maturing in 2021.
When issued, the Ordinary Shares under the block listing will rank pari passu with the Company's existing issued Ordinary Shares. It is expected that admission will be effective on 11 January 2021.
| Contacts: | |
| | |
| CVS Group plc | via MHP Communications |
| Richard Fairman, CEO | |
| Juliet Dearlove, Company Secretary | |
| | |
| | |
| N+1 Singer (Nominated Adviser & Broker) | +44 20 7496 3000 |
| Aubrey Powell / Jen Boorer (Corporate Finance) | |
| Rachel Hayes (Corporate Broking) | |
| | |
| | |
| MHP Communications (Financial PR) | +44 20 3128 8549 |
| Andrew Jaques / Rachel Mann / Charles Hirst | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
